Vascularized cancer on a chip: The effect of perfusion on growth and drug delivery of tumor spheroid.


Journal

Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316

Informations de publication

Date de publication:
01 2020
Historique:
received: 31 05 2019
revised: 11 10 2019
accepted: 14 10 2019
pubmed: 12 11 2019
medline: 15 5 2021
entrez: 12 11 2019
Statut: ppublish

Résumé

Tumor vasculature creates a hostile tumor microenvironment (TME) in vivo and nourishes cancers, resulting in cancer progression and drug resistance. To mimic the biochemical and biomechanical environments of tumors in vitro, several models integrated with a vascular network have been reported. However, the tumor responses to biochemical and biomechanical stimuli were evaluated under static conditions and failed to incorporate the effects of blood flow to tumors. In this study, we present a tumor-on-a-chip platform that enables the evaluation of tumor activities with intraluminal flow in an engineered tumor vascular network. The fibroblasts in the tumor spheroid induced angiogenic sprouts, which constructed a perfusable vascular network in a tumor spheroid. The perfusability of the engineered vascular network was preserved during the culture. Moreover, perfusion for over 24 h significantly increased the proliferation activities of tumor cells and decreased cell death in the spheroid. Drug administration under perfusion condition did not show the dose-dependent effects of anticancer drugs on tumor activities in contrast to the results under static conditions. Our results demonstrate the importance of flow in a vascular network for the evaluation of tumor activities in a drug screening platform.

Identifiants

pubmed: 31710953
pii: S0142-9612(19)30646-5
doi: 10.1016/j.biomaterials.2019.119547
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

119547

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Yuji Nashimoto (Y)

Department of Micro Engineering, Kyoto University, Kyoto, 615-8540, Japan; Frontier Research Institute for Interdisciplinary Sciences (FRIS), Tohoku University, Miyagi, 980-8578, Japan; Graduate School of Engineering, Tohoku University, Miyagi, 980-8579, Japan.

Ryu Okada (R)

Department of Micro Engineering, Kyoto University, Kyoto, 615-8540, Japan.

Sanshiro Hanada (S)

International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, 860-0811, Japan.

Yuichiro Arima (Y)

International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, 860-0811, Japan.

Koichi Nishiyama (K)

International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, 860-0811, Japan.

Takashi Miura (T)

Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.

Ryuji Yokokawa (R)

Department of Micro Engineering, Kyoto University, Kyoto, 615-8540, Japan. Electronic address: ryuji@me.kyoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH